Related Experiment Video
Updated: Jun 26, 2025
07:30
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
7.3K
Is it now time to prepare psychiatry for a psychedelic future?
David Nutt1, Ilana Crome2, Allan H Young3
1Division of Psychiatry, Imperial College London, UK; and Drug Science, London, UK.
Summary
Australia is rescheduling psilocybin and MDMA for mental health conditions. This move presents new opportunities and challenges for psychiatric communities and healthcare systems to explore novel therapeutic approaches.
Area of Science:
- Psychiatry and Pharmacology
- Neuroscience and Mental Health Treatment
Background:
- Australia has rescheduled psilocybin and MDMA under UN conventions.
- These substances are now designated for treating treatment-resistant depression and post-traumatic stress disorder, respectively.
Purpose of the Study:
- To explore the reasons behind Australia's rescheduling of psilocybin and MDMA.
- To examine the opportunities and challenges presented to psychiatric communities.
- To outline potential responses from psychiatric and health systems.
Main Methods:
- Review of rescheduling policies and regulatory changes.
- Analysis of clinical trial data and therapeutic potential.
- Exploration of psychiatric community and healthcare system readiness.
Main Results:
- Rescheduling reflects growing evidence for psychedelic-assisted therapies.
- Significant opportunities exist for novel treatment paradigms.
- Challenges include regulatory hurdles, training, and public perception.
Conclusions:
- The rescheduling marks a significant shift in mental health treatment policy.
- Psychiatric communities and health systems must adapt to integrate these novel therapies.
- Proactive planning is crucial for responsible implementation and maximizing patient benefit.
More Related Videos
04:44Author Spotlight: Studying Drug Impacts on Brain Signals Using Dual LFP Recording Protocol in Mice
Published on: February 16, 2024
1.5K
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
8.9K
Related Concept Videos
01:27Hallucinogens and Psychedelics
163
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
163
01:22CNS Stimulants: Psychedelic Agents
147
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
147
01:26Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
01:06Altered States of Awareness
179
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
179
01:30Psychosurgery
53
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
53